Clinical Research Evaluations COMING SOON!
Based out of our South Omaha location!
Emphasis on total well being. Our research opportunities will allow us to provide a variety of treatments and studies including: migraines, vaccines, blood pressure, COPD and so much more!
Diversity and inclusion in clinical trials is critical. Clinical research evaluations ensure that scientific advancements benefit diverse communities. These considerations include factors such as race, ethnicity, age, sex, and sexual orientation. The more broad the audience the better the data.
Based in experience. We are here for your entire family. With our staff experience ranging from infants to elderly patients, we are ready to provide. you with the care you need.
Access to cutting edge services, treatments and medications. We pride ourselves in using the latest techniques and offering cutting edge services for our patients. We believe in expanding our medical “toolsets” to enhance our approach to patient health. We strive to provide cutting edge services to a diverse range of patients from all demographic backgrounds.
By performing clinical trials under controlled environment and following the science method, researchers can better understand the effectiveness of new treatments and therapies. These trials typically involve human participants and are conducted in several phases to test different aspects of the treatment, including its safety, dosage, efficacy, and side effects.
Clinical research evaluations are crucial because they help identify new treatments and therapies that can improve health outcomes and save lives. By testing these treatments in controlled environments with rigorous scientific methods researchers can determine whether they are safe and effective for use in the general population. This helps to ensure that patients receive the best possible care, while also advancing our understanding of diseases. Additionally, clinical research evaluations can help to identify potential risks and side effects of treatments, leading to better informed decisions and improved patient safety.
It is important to have minorities in clinical research evaluations because different ethnic and racial groups may respond differently to treatments due to genetic and environmental factors, including differences in lifestyle, culture, and healthcare access. Thus, by including a diverse group of participants in clinical trials, researchers can better understand how different populations may react to treatments and develop more personalized and effective healthcare interventions. This can also help to address healthcare disparities and ensure that new treatments and therapies are accessible and appropriate for everyone, regardless of their background or identity.
In the past, clinical trials often failed to include participants who accurately represented the demographics most impacted by specific diseases or conditions. For example, many trials predominantly enrolled White individuals, resulting in significant knowledge gaps regarding diseases, preventative measures, and treatment efficacy across diverse populations. These differences reduce our ability to make informed healthcare decisions, risk reduction strategies, optimal treatment plans, and the advancement of more effective medications or interventions.
Quality Clinical Research (QCR) originated here in Omaha , NE in 2003. Since their opening they have hosted several studies in phases 2 through 4. They have highly skilled medical staff that undergo continuous educational and professional training to provide the best quality in healthcare to their patients. QCR is associated with some of Omaha ‘s best physicians. From family physicians to specialist, they have a wide range of knowledge and experience.
New services alert | Clinical Research Evaluations
SOMA is teaming up with Quality Clinical Research (QCR) to bring exciting new opportunities to South Omaha! Come find us during the Cinco de Mayo events this weekend to learn about studies we will be conducting, freebies, and how we can help your family.
Who is QCR?
Quality Clinical Research (QCR) originated here in Omaha , NE in 2003. Since their opening they have hosted several studies in phases 2 through 4. They have highly skilled medical staff that continue in education and training in order to provide the best Quality in healthcare to their patients. QCR is associated with some of Omaha 's best physicians. From family physicians to specialist, they have a wide range of knowledge and experience.
Why Clinical Research?
Clinical research evaluations involve studying the safety and effectiveness of new treatments, medications, medical devices, and procedures through carefully designed clinical trials. These trials typically involve human participants and are conducted in several phases to test different aspects of the treatment, including its safety, dosage, efficacy, and side effects.
Clinical research evaluations are crucial because they help identify new treatments and therapies that can improve health outcomes and save lives. By testing these treatments in controlled environments with rigorous scientific methods researchers can determine whether they are safe and effective for use in the general population. This helps to ensure that patients receive the best possible care, while also advancing our understanding of diseases and their underlying mechanisms. Additionally, clinical research evaluations can help to identify potential risks and side effects of treatments, leading to better informed decisions and improved patient safety.
Minority Involvement is critical.
It is important to have minorities in clinical research evaluations because different ethnic and racial groups may respond differently to treatments due to genetic and environmental factors, including differences in lifestyle, culture, and healthcare access. Thus, by including a diverse group of participants in clinical trials, researchers can better understand how different populations may react to treatments and develop more personalized and effective healthcare interventions. This can also help to address healthcare disparities and ensure that new treatments and therapies are accessible and appropriate for everyone, regardless of their background or identity.